Both regimens “can be considered standard chemotherapy options” for high-risk, HR-positive early breast cancer, said Sherko Kuemmel, MD, PhD.

BCG therapy is associated with a high frequency of side effects in NMIBC; however, when used in sequential combination with ...

Probiotics may help with many health conditions. Although they're generally safe, it's important to talk with your doctor ...

A MUM has shared a shocking photo of a giant lump protruding from her breast, which doctors repeatedly dismissed a benign. But after months of being told there was nothing to worry about, Tirzah ...

Prostate cancer is one of the most prevalent cancers among men and poses a significant health concern, with its incidence on the rise. In Thailand, it is the 4th most common cancer among men (1), ...

30 jan 2025 FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain Today, the U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets ...

Dr Rebecca Dobson discussed the acute need to assess cardiovascular risk in cancer care, cardiotoxicity and the MDT in cardio ...

on Thursday approved a new type of prescription pain medication for adults to treat moderate to severe acute pain. The drug, called Journavx (suzetrigine) and manufactured by biotech company ...

The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than two decades. The drug, suzetrigine, is a 50-milligram prescription pill ...

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side effects.

With this approval, Vertex becomes the first pharmaceutical company in 25 years to introduce a new class of pain medication in the United States. This milestone marks a breakthrough after years of ...